glp 1 liver function Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide Receptor Agonists in Nonalcoholic Fatty Disease 💉𝗚𝗟𝗣-𝟭 𝗺𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝘂𝘀𝘂𝗮𝗹𝗹𝘆 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱

One small randomized controlled trial found that exenatide significantly lowered ICP within hours

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control

Application of GLP-1R agonists in AD Several studies have reported that GLP-1 agonists could protect brain against various damage in AD models ( Supplementary Table 1 and Table 1 )

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States